The Beauty Health Company (SKIN) Misses Q1 EPS by 14c

The Beauty Health Company (NASDAQ: SKIN) reported Q1 EPS of ($0.17), $0.14 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $86.3 million versus the consensus estimate of $90.69 million.

GUIDANCE:

The Beauty Health Company sees FY2023 revenue of $460-480 million, versus the consensus of $456.4 million.

• Adjusted EBITDA margin(1) 18% – 20%

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Stifel Starts Victrex Plc. (VCT:LN) (VTXPF) at Buy
• Wintermar acquires full control of Fast Offshore Supply, adding 5 new CTVs